U.S. Vaccine Panel Delays Vote on J&J Covid-19 Shot’s Clot Danger

The federal authorities’s advice to pause utilizing Johnson & Johnson’s Covid-19 vaccine will stay in place after an advisory panel postpone a vote on the way to transfer ahead following studies of some instances of life-threatening blood clots.

The Advisory Committee on Immunization Practices, or ACIP, stated Wednesday it doesn’t have sufficient data but in regards to the threat of those uncommon unwanted effects to find out whether or not the vaccine needs to be continued, discontinued or advisable just for sure teams of the inhabitants.

The ACIP expects to fulfill once more in one other week or two to revisit the difficulty. U.S. well being officers on Tuesday advisable that use of the J&J vaccine be paused whereas they examine.

The ACIP, which advises the Facilities for Illness Management and Prevention on vaccination coverage, met to assessment medical information gathered up to now on six ladies between the ages of 18 and 48 years previous who developed clots in vessels draining blood from their brains and in some instances different components of the physique after receiving J&J’s vaccine.

One 45-year-old girl died. Three others stay within the hospital, two of whom are intensive care, the CDC stated. The remaining two have been discharged from the hospital.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.